Author

A. Snell

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Immunology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Organism:human· 2 Assay:proteomics· 2 Organism:bacteria (other)· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Research Focus:gene regulatory network inference· 1

Frequent Co-Authors

A. Berger· 1 shared A. K. Riley· 1 shared A. Urisman· 1 shared A. Vichas· 1 shared D. Manias· 1 shared E. N. Gallichotte· 1 shared G. D. Ebel· 1 shared G. M. Dunny· 1 shared

Activity by Year

2022-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 12 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Berger

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Arginine impacts aggregation, biofilm formation, and antibiotic susceptibility in Enterococcus faecalis

J. Willett, A. Snell, D. Manias, R. Elbehery, G. M. Dunny

This study shows arginine reduces E. faecalis biofilm formation, alters gene expression, increases aggregation, and decreases susceptibility to antibiotics.

bioRxiv · May 30, 2024 · PreprintMicrobiology

The deubiquitinase USP9X regulates RIT1 protein abundance and oncogenic phenotypes

A. K. Riley, M. Grant, A. Snell, A. Vichas, S. Moorthi, A. Urisman, P. Castel, L. Wan, A. Berger

This study shows that USP9X stabilizes RIT1 protein and that its depletion reduces RIT1 abundance and sensitizes cells to EGFR inhibitors.

bioRxiv · Nov 30, 2023Cancer Biology

Impact of prior infection on SARS-CoV-2 antibody responses in vaccinated long-term care facility staff

E. N. Gallichotte, M. Nehring, S. Stromberg, M. C. Young, A. Snell, J. B. Daniels, K. L. Pabilonia, S. Vandewoude, N. Ehrhart, G. D. Ebel

This study examines how prior SARS-CoV-2 infection affects antibody responses to vaccination in long-term care facility staff, finding higher antibody levels in previously infected individuals and no booster response in those with prior immunity.

bioRxiv · Apr 4, 2022Immunology